Rapport Therapeutics, Inc. (RAPP) vs Syndax Pharmaceuticals, Inc. (SNDX)
Rapport Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Rapport Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($1.6B and $1.6B). Rapport Therapeutics, Inc. has the higher net margin (0.00% vs −87.6%) and the higher return on invested capital (0.00% vs −247.9%). Across the 13 metrics below, Rapport Therapeutics, Inc. leads on 11 and Syndax Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | RAPP | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 95.78% | 65.16% |
| Operating margin | 0.00% | (77.05%) | 0.00% |
| Net margin | 0.00% | (87.60%) | 0.00% |
| Free cash flow margin | 0.00% | (87.64%) | 0.00% |
| Return on equity | (39.96%) | (255.93%) | (57.72%) |
| Return on assets | (36.85%) | (33.97%) | (49.22%) |
| Return on invested capital | 0.00% | (247.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack